Yes Tom. Unlike many BD1 is on the road to commercialisation of its product.
I see the assays being successfully switched to Luminex as the DFS if you like and the FID (final investment decision) as the end of clinical trials from the above.
Worlds first blood test for Ovarian, Breast cancer that can differentiate between benign and cancerous tumours will IMO be very much sought after.
Mammograms have less sensitivity and specificity and can't differentiate yet are used globally. I can see the day when squashing a women's breast will disappear and be replaced by this test. Aimo DB
Chart, page-2694
-
- There are more pages in this discussion • 1,436 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
57.5¢ |
Change
-0.005(0.86%) |
Mkt cap ! $63.40M | |||
| Open | High | Low | Value | Volume |
| 58.0¢ | 58.0¢ | 56.0¢ | $53.11K | 91.93K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8400 | 56.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 58.0¢ | 33187 | 1 |
View Market Depth
| Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |